|
1.
|
Scheuer A, Grün R and Lehman FG: Peptide
hormones in liver cirrhosis and hepatocellular carcinoma. Oncodev
Biol Med. 2:1–10. 1981.PubMed/NCBI
|
|
2.
|
Parkes DG, Yamamoto GY, Vaughan JM and
Vale WW: Characterization and regulation of
corticotrophin-releasing factor in the human hepatoma NPLC-KC cell
line. Neuroendocrinology. 57:663–669. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Nawata H, Higuchi K, Ikuyama S, Kato K,
Ibayashi H, Mimura K, Sueshi K, Zingami H and Imura H:
Corticotrophin-releasing hormone- and adrenocorticotropin-producing
pituitary carcinoma with metastases to the liver and lung in a
patient with Cushing’s disease. J Clin Endocrinol Metab.
71:1068–1073. 1990.PubMed/NCBI
|
|
4.
|
Mowat NA, Edwards CR, Fischer R, McNeilly
AS, Green JR and Dawson AM: Hypothalamic-pituitary-gonadal function
in men with cirrhosis of the liver. Gut. 17:345–350. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Van Thiel DH, Lester R and Vaitukaitis J:
Evidence for a defect in pituitary secretion of luteinizing hormone
in chronic alcoholic men. J Clin Endocrinol Metab. 47:499–507.
1978.PubMed/NCBI
|
|
6.
|
Wang YJ, Wu JC, Lee SD, Tsai YT and Lo KJ:
Gonadal dysfunction and changes in sex hormones in postnecrotic
cirrhotic men: a matched study with alcoholic men.
Hepatogastroenterology. 38:531–534. 1991.PubMed/NCBI
|
|
7.
|
Bell H, Raknerud N, Falch JA and Haug E:
Inappropriately low levels of gonadotrophins in amenorrhoeic women
with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol.
132:444–449. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Zietz B, Lock G, Plach B, Drobnik W,
Grossmann J, Schölmerich J and Straub RH: Dysfunction of the
hypothalamic-pituitary-glandular axes and relation to Child-Pugh
classification in male patients with alcoholic and virus-related
cirrhosis. Eur J Gastroenterol Hepatol. 15:495–501. 2003.PubMed/NCBI
|
|
9.
|
Zhang J, Huang G and Huang W: Gonadotropin
releasing hormone and its receptor in the tissue of human
hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 78:343–346.
1998.(In Chinese).
|
|
10.
|
Manesis EK, Giannoulis G, Zoumboulis P,
Vafiadou I and Hadziyannis SJ: Treatment of hepatocellular
carcinoma with combined suppression and inhibition of sex hormones:
a randomized, controlled trial. Hepatology. 21:1535–1542.
1995.PubMed/NCBI
|
|
11.
|
Eaveri R, Ben-Yehudah A and
Lorberboum-Galski H: Surface antigens/receptors for targeted cancer
treatments: the GnRH receptor/binding site for targeted
adenocarcinoma therapy. Curr Cancer Drug Targets. 4:673–687. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Ataseven H, Bahcecioglu IH, Kuzu N, et al:
The levels of grelin, leptin, TNF-alpha, and IL-6 in liver
cirrhosis and hepatocellular carcinoma due to HDV infection.
Mediators Inflamm. 2006:783802006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Berasain C, Castillo J, Perugorria MJ,
Prieto J and Avila MA: Amphiregulin: a new growth factor in
hepatocarcinogenesis. Cancer Lett. 254:30–41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ehrenfried JA, Zhou Z, Thompson JC and
Evers BM: Expression of the neurotensin gene in fetal human liver
and fibrolamellar carcinoma. Ann Surg. 220:484–489. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Xidakis C, Mastrodimou N, Notas G, Renieri
E, Kolios G, Kouroumalis E and Thermos K: RT-PCR and
immunocytochemistry studies support the presence of somatostatin,
cortistatin and somatostatin receptor subtypes in rat Kupfer cells.
Reg Pept. 143:78–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Raderer M, Hejna MH, Muller C, Kornek GV,
Kurtaran A, Virgolini I, Fiebieger W, Hamilton G and Scheithauer W:
Treatment of hepatocellular cancer with the long acting
somatostatin analog lanreotide in vitro and in vivo.
Int J Oncol. 16:1197–1201. 2000.PubMed/NCBI
|
|
17.
|
Katsumata N, Chakraborty C, Myal Y,
Schroedter IC, Murphy LJ, Shiu RP and Friesen HG: Molecular cloning
and expression of peptide 23, a growth hormone-releasing
hormone-inducible pituitary protein. Endocrinology. 136:1332–1339.
1995.PubMed/NCBI
|
|
18.
|
Caplin M, Khan K, Savage K, Rode J, Varro
A, Michaeli D, Grimes S, Brett B, Pounder R and Dhillon A:
Expression and processing of gastrin in hepatocellular carcinoma,
fibrolamellar carcinoma and cholangiocarcinoma. J Hepatol.
30:519–526. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Körner M, Hayes GM, Rehmann R, Zimmermann
A, Scolz A, Wiedenmann B, Miller LJ and Reubi JC: Secretin
receptors in the human liver: expression in billiary tract and
cholangiocarcinoma, but not in hepatocytes or hepatocellular
carcinoma. J Hepatol. 45:825–835. 2006.
|
|
20.
|
Christofides ND: Pancreatic glucagons.
Radioimmunoassay of Gut Regulatory Peptides. Bloom SR and Long GL:
WB Saunders Company Ltd; pp. 741982
|
|
21.
|
Thorton JR and Losowsky MS: Methionine
enkephalin is increased in plasma in acute liver disease and is
present in bile and urine. J Hepatol. 8:53–59. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Yudaydin C: The central opioid system in
liver disease and its complications. Metab Brain Dis. 16:79–83.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Davis M: Cholestasis and endogenous
opioids: liver disease and exogenous opioid pharmacokinetics. Clin
Pharmacokinet. 46:825–850. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hsi KL, Seidah NG, De Serres G and
Chrétien M: Isolation and NH2-terminal sequence of a novel porcine
anterior pituitary poly-peptide. Homology to proinsulin, secretin
and Rous sarcoma virus transforming protein TVFV60. FEBS Lett.
147:261–266. 1982. View Article : Google Scholar
|
|
25.
|
Seidah NG, Hsi KL, De Serres G, Rochemont
J, Hamelin J, Antakly T, Cantin M and Chrétien M: Isolation and
NH2-terminal sequence of a highly conserved human and porcine
pituitary protein belonging to a new superfamily.
Immunocytochemical localization in pars distalis and pars nervosa
of the pituitary and in the supraoptic nucleus of the hypothalamus.
Arch Biochem Biophys. 225:525–534. 1983.
|
|
26.
|
Venetikou MS: 7B2: In vitro and in vivo
studies on a new pituitary protein. PhD thesis. Senate House;
London, UK: 1992
|
|
27.
|
Mbikay M, Seidah NG and Chrétien M:
Neuroendocrine protein 7B2: structure, expression and functions.
Biochem J. 357:329–342. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Natori S, Iguchi H, Nawata H, Kato K,
Ibayashi H and Chretien M: Age-related change in plasma
concentration of 7B2 (a novel pituitary polypeptide) in normal
humans. Life Sci. 41:977–981. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Iguchi H, Natori S, Ou Y, Nawata H, Kato
K, Ibayashi H and Bloom SR: Plasma levels of 7B2 (a novel pituitary
polypeptide) and its molecular forms in plasma and urine in
patients with chronic renal failure: possible degradation by the
kidney. Reg Pept. 21:263–270. 1988. View Article : Google Scholar
|
|
30.
|
Leonhardt UT, Stevenson JC, Ghatei MA,
Lischka A, MacDonald DW, Whitehead MI and Bloom SR: Elevated 7B2
levels during normal human pregnancy. Am J Obstet Gynecol.
158:1141–1144. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Suzuki H, Kobori H, Ohtake R, Hashigami Y,
Suzuki Y, Shimoda Sl and Bloom SR: Circulating concentrations of
immunoreactive peptide 7B2 in certain pathophysiological conditions
and response to oral glucose load. Clin Chem. 34:410–413.
1988.PubMed/NCBI
|
|
32.
|
Suzuki H, Christofides ND, Chretien M,
Seidah NG, Polak JM and Bloom SR: A novel pituitary protein (7B2)
in the rat urogenital tract. Biomed Res. 6:139–143. 1985.
|
|
33.
|
Hunter WH and Greenwood FC: Preparation of
iodine-131 labelled human growth hormone of high specific activity.
Nature. 194:495–496. 1962. View
Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Laurent TC and Killander J: A theory of
gel filtration and its experimental verification. J Chromatogr A.
14:317–330. 1964. View Article : Google Scholar
|
|
35.
|
Kobori H: Immunoreactive 7B2
concentrations in plasma and cerebrospinal fluid in
pathophysiological conditions and the responses to oral glucose
load, intravenous LHRH, TRH and arginine infusion. Nihon Naibunpi
Gakkai Zasshi. 65:1135–1148. 1989.(In Japanese).
|
|
36.
|
Suzuki H, Ghatei MA, Williams SJ,
Uttenthall LO, Facer P, Bishop AE, Polak JM and Bloom SR:
Production of pituitary protein 7B2 immunoreactivity by endocrine
tumours and its possible diagnostic value. J Clin Endocrinol Metab.
63:758–765. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Suzuki H, Christofides ND, Chretien M,
Seidah NG, Polak JM and Bloom SR: Developmental changes in
immunoreactive content of novel pituitary protein 7B2 in human
pancreas and its identification in pancreatic tumours. Diabetes.
36:1276–1279. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Azzoni C, Yu JY, Baggi MT, D’Adda T,
Timson C, Polak JM and Bordi C: Studies on co-localization of 7B2
and pancreatic hormones in normal and tumoural islet cells.
Virchows Arch A Pathol Anat Histopathol. 421:457–466. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Vieau D, Linard CG, Mbikay M, Lenne F,
Chretien M, Luton JP and Bertagna X: Expression of the
neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Clin Endocrinol (Oxf). 36:597–603. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Iguchi H, Hara N, Hayashi I, Ohta M, Bloom
SR and Chrétien M: Elevation of a novel pituitary protein (7B2) in
the plasma in small cell carcinoma of the lung. Eur J Cancer Clin
Oncol. 25:1225–1232. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Roebroek AJ, Martens GJ, Duits AJ,
Schalken JA, van Bokhoven A, Wagenaar SS and van de Ven WJ:
Differential expression of the gene encoding the novel pituitary
polypeptide 7B2 in human lung cancer cells. Cancer Res.
49:4154–4158. 1989.PubMed/NCBI
|
|
42.
|
Kapuscinski M, Schulkes A, Read D and
Hardy KJ: Expression of neurotensin in endocrine tumors. J Clin
Endocrinol Metab. 70:100–106. 1990. View Article : Google Scholar
|
|
43.
|
Ito H, Masuda H, Tahara E and Wittekind C:
Carcinoid tumor of the liver. Dtsch Med Wochenschr. 114:623–627.
1989.(In German).
|
|
44.
|
Marzioni M, Fava G and Benedetti A:
Nervous and neuroendocrine regulation of the pathophysiology of
cholestasis and of biliary carcinogenesis. World J Gastroenterol.
12:3471–3480. 2006.PubMed/NCBI
|
|
45.
|
Osamura RY, Chrétien M and Marcinkiewicz
M: Ultrastructural localization of secretory granule constituent
chromogranin and 7B2. Pathol Res Pract. 183:617–619. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Ozawa H and Takata K: The granin family -
its role in sorting and secretory granule formation. Cell Struct
Funct. 20:415–420. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Qin LX and Tang ZY: The prognostic
molecular markers in hepatocellular carcinoma. World J
Gastroenterol. 8:385–392. 2002.PubMed/NCBI
|
|
48.
|
Geller SA, Dhall D and Alsabeh R:
Application of immunocytochemistry to liver and gastrointestinal
neoplasms: liver, stomach, colon, and pancreas. Arch Pathol Lab
Med. 132:490–499. 2008.PubMed/NCBI
|
|
49.
|
Braks JA and Martens GJ: 7B2 is a
neuroendocrine chaperone that transiently interacts with prohormone
convertase PC2 in the secretory pathway. Cell. 78:263–273. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Shennan KI, Taylor NA and Docherty K:
Calcium- and pH-dependent aggregation and membrane association of
the precursor of the prohormone convertase PC2. J Biol Chem.
269:18646–18650. 1994.PubMed/NCBI
|
|
51.
|
Jan G, Taylor NA, Scougall KT, Docherty K
and Shennan KI: The propeptide of the prohormone convertase PC2
acts as a transferable aggregation and membrane-association signal.
Eur J Biochem. 257:41–46. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Lloyd RV, Jin L, Qian X, Scheithauer BW,
Young WF Jr and Davis DH: Analysis of the chromogranin A
post-translational cleavage product pancreastatin and the
prohormone convertase PC2 and PC3 in normal and neoplastic human
pituitaries. Am J Pathol. 146:1188–1198. 1995.
|
|
53.
|
Takumi I, Steiner DF, Sanno N, Teramoto A
and Osamura RY: Localization of prohormone convertases 1/3 and 2 in
the human pituitary gland and pituitary adenomas: analysis by
immunocytochemistry, immunoelectron microscopy, and laser scanning
microscopy. Mod Pathol. 11:232–238. 1998.
|
|
54.
|
Westphal CH, Muller L, Zhou A, Zhu X,
Bonner-Weir S, Schambelan M, Steiner DF, Lindberg I and Leder P:
The neuroendocrine protein 7B2 is required for peptide hormone
processing in vivo and provides a novel mechanism for pituitary
Cushing’s disease. Cell. 96:689–700. 1999.PubMed/NCBI
|
|
55.
|
Laurent V, Kimble A, Peng B, Zhu P, Pintar
JE, Steiner DF and Lindberg I: Mortality in 7B2 null mice can be
rescued by adrenalectomy. Involvement of dopamine in ACTH
hypersecretion. Proc Natl Acad Sci USA. 99:3087–3092. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Venetikou MS, Burrin JM, Ghatei MA and
Bloom SR: ACTH and 7B2 release by atT-20 cells in vitro: effect of
CRF, VIP, AVP and SRIF during perifusion and static culture. FEBS
J. 275(Suppl): 2622008.
|
|
57.
|
Natori S, Iguchi H, Nawata H, Kato K,
Ibayashi H, Nagasaki H and Chrétien M: Evidence for the release of
a novel pituitary polypeptide (7B2) from the growth
hormone-producing pituitary adenoma of patients with acromegaly. J
Clin Endocrinol Metab. 66:430–437. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Natori S, Iguchi H, Ohasi M, Nakao R,
Bloom SR and Nawata H: Effect of octapeptide analogue (SMS 201–995)
on plasma 7B2 (a neuroendocrine polypeptide) levels in patients
with acromegaly. Clin Endocrinol (Oxf). 32:49–55. 1990.
|
|
59.
|
Sarac MS, Zieske AW and Lindberg I: The
lethal form of Cushing’s in 7B2 null mice is induced by multiple
metabolic and hormonal abnormalities. Endocrinology. 143:2324–2332.
2002.
|
|
60.
|
Seidel B, Dong W, Savaria D, Zheng M,
Pintar JE and Day R: Neuroendocrine protein 7B2 is essential for
proteolytic conversion and activation of proprotein convertase 2 in
vivo. DNA Cell Biol. 17:1017–1029. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Tzimas GN, Chevet E, Jenna S, Nguyên DT,
Khatib AM, Marcus V, Zhang Y, Chrétien M, Seidah NG and Metrakos P:
Abnormal expression and processing of the proprotein convertase PC1
and PC2 in human colorectal liver metastases. BMC Cancer.
17:1492005. View Article : Google Scholar : PubMed/NCBI
|
